Call Options

15 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $3.09 Million - $3.84 Million
-4,000 Reduced 8.05%
45,700 $40.5 Million
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $6.45 Million - $8.09 Million
-8,900 Reduced 15.19%
49,700 $45 Million
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $6.87 Million - $9.19 Million
-11,600 Reduced 16.52%
58,600 $45.6 Million
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $3.1 Million - $3.65 Million
-5,900 Reduced 7.75%
70,200 $40.9 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $11.4 Million - $15.7 Million
26,200 Added 52.51%
76,100 $40.9 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $15.5 Million - $20.7 Million
44,100 Added 760.34%
49,900 $23.4 Million
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $124,252 - $145,928
-400 Reduced 6.45%
5,800 $1.99 Million
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $643,100 - $749,340
-2,000 Reduced 24.39%
6,200 $2.27 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $2.43 Million - $2.77 Million
8,200 New
8,200 $2.65 Million
Q2 2020

Aug 14, 2020

SELL
$136.42 - $164.18 $1.16 Million - $1.4 Million
-8,500 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$119.05 - $147.35 $4.04 Million - $5 Million
-33,900 Reduced 79.95%
8,500 $1.18 Million
Q4 2019

Feb 14, 2020

SELL
$106.92 - $132.43 $7.97 Million - $9.87 Million
-74,500 Reduced 63.73%
42,400 $5.57 Million
Q3 2019

Nov 14, 2019

BUY
$106.79 - $116.16 $8.22 Million - $8.94 Million
77,000 Added 192.98%
116,900 $13.1 Million
Q2 2019

Aug 14, 2019

BUY
$110.79 - $129.32 $3.7 Million - $4.32 Million
33,400 Added 513.85%
39,900 $4.42 Million
Q1 2019

May 15, 2019

BUY
$111.31 - $131.02 $723,515 - $851,630
6,500 New
6,500 $843,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $760B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.